Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kiyokazu Komori"'
Autor:
Senju R, Tsunehiko Asai, Kiyokazu Komori, Jun-ichi Kadota, S. Kawamoto, Kohei Hara, Hiroshi Mukae, Hiroshige Oda, Chieko Shukuwa, Shiro Kusano, M. Kaseda, Hideaki Sawa, Nobuo Morikawa, Kazuhito Hiratani, Osamu Sakito, Atsushi Yokoyama, Toru Morikawa, Kiyoyasu Fukushima, Masaki Hirota, Shigeru Kohno
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 66:194-200
Recently, "low dose and long term" erythromycin (EM) treatment has been reported as effective on chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB). However the effective mechanism of EM is still obscure. In this study,
Autor:
Rinzo SOEJIMA, Yoshihito NIKI, Jiro HINO, Toshio KISHIMOTO, Yoshihisa NAKAGAWA, Masaru SUMI, Akira SAITO, Ichiro NAKAYAMA, Masumi TOMIZAWA, Yomei HIRAGA, Susumu ITO, Masao TAMURA, Takashi ITO, Takashi TUSRUYA, Hitoshi KOBAYASHI, Hiroshi KURAMITSU, Kazutoshi GOMI, Tamotsu TAKISHIMA, Shiroh IDA, Isao OHNO, Kiyoshi KONNO, Kotaro OIZUMI, Akira WATANABE, Seiichi AONUMA, Yushi NAKAI, Kousaku NAGAI, Kazuo SATOH, Izumi HAYASHI, Osamu SEKINE, Nobuki AOKI, Masataka KATSU, Shinji OKUI, Hisashi TAKIZUKA, Koichiro ASANO, Rieko AMAGAI, Kaoru SHIMADA, Yasuyuki SANO, Yasuhumi MIYAMOTO, Tadashi MIYAHARA, Jingoro SHIMADA, Kohya SHIBA, Hideo IKEMOTO, Kazuyoshi WATANABE, Junzaburo KABE, Koichiro KUDOH, Hiroichi TANIMOTO, Koichiro NAKATA, Yoshitaka NAKAMORI, Tatsuo NAKATANI, Naohiko CHONABAYASHI, Kentaro WATANABE, Masaru KOYAMA, Tatsuo KATO, Toshiaki TOMI, Hiroyuki KOBAYASHI, Hiroaki TAKEDA, Masahide KAWAHIRA, Ippei FUJIMORI, Mitsuo OBANA, Takao OKUBO, Akira ITOH, Hirotada IKEDA, Fumio MATSUMOTO, Kaoru OYAMA, Toshihiko TAKEUCHI, Masahito KATO, Yoshihiro UEDA, Hiroshi OKUBO, Hidekazu HANAKI, Fumio MIKI, Keiji KOBAYASHI, Yoji SHIMIZU, Kenzo SHIOTA, Michio YAMAKIDO, Kenji HASEGAWA, Koichi AWAYA, Toyofumi MITSUYAMA, Osamu KURIMURA, Hideo SASAKI, Hirofumi FUKUHARA, Yoshiro SAWAE, Koji TAKAGI, Osamu KOHASHI, Nobuaki SHIGEMATSU, Masayuki MIYAZAKI, Katsuro YAGAWA, Ken-ichi OGATA, Toshihiko KOGA, Masahide TAKII, Hidenobu SHIGEOKA, Yoshihiro KATOH, Masaru NASU, Hideaki SHIGENO, Jun GOTO, Takayoshi TASHIRO, Kohei HARA, Keizo YAMAGUCHI, Shigeru KOHNO, Toshiaki HAYASHI, Hiroshi TOMITA, Naoshi SUYAMA, Akira YASUOKA, Kazuo SASAYAMA, Kiyokazu KOMORI, Toshiyuki OHE, Kin-ichi IZUMIKAWA, Hideo MASUMOTO, Mitsuo KAKU, Keizo MATSUMOTO, Naoto RIKITOMI, Tsuyoshi NAGATAKE, Masakazu TAKASUGI, Harumi SISIDO, Kiyoshi SHIMA, Taeo TAKENAKA, Atsushi SAITO, Yoshiteru SHIGENO, Yuei IRABU, Kazunori TAMAKI
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 63(5)
The clinical efficacy and safety of Roxithromycin (RU) were compared with those of Midecamycin acetate (MOM) in patients with pneumonia in a double blind study. RU and MOM were administered orally for 14 days with daily doses of 300 mg (150 mg b.i.d.
Publikováno v:
American journal of clinical pathology. 72(3)
IgA-bearing peripheral blood lymphocytes, serum IgA, urinary sediments and HLA types of patients with IgA nephropathy and members of their families were examined to elucidate whether some familial factors might be related to the development of IgA ne